Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study
| Autor: | Karayama, Masato, Suda, Takafumi, Yoh, Kiyotaka, Usui, Kazuhiro, Hosomi, Yukio, Kishi, Kazuma, Naka, Go, Watanabe, Kageaki, Tamano, Shu, Uemura, Kohei, Kunitoh, Hideo |
|---|---|
| Zdroj: | In Lung Cancer December 2024 198 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect